For the fungal pathogen Candida albicans, genetic overexpression readily occurs via a diversity of genomic alterations, such as aneuploidy and gain-of-function mutations, with important consequences for host adaptation, virulence, and evolution of antifungal drug resistance. Given the important role of overexpression on C. albicans biology, it is critical to develop and harness genetic tools that enable the analysis of genes expressed at high levels in the fungal cell. Here, we describe the development, optimization, and application of a novel, single-plasmid-based CRISPR activation (CRISPRa) platform for targeted genetic overexpression in C. albicans. Our CRISPRa system exploits a nuclease-dead dCas9 fused to the tripartite activator complex VP64-p65-Rta (VPR), and a Golden Gate site for efficient guide RNA cloning to overexpress genes of interest. Using this system, we demonstrate the ability of CRISPRa to drive high levels of gene expression in C. albicans, and we assess optimal guide RNA targeting for robust overexpression. We further demonstrate the application of CRISPRa to overexpress genes involved in fungal pathogenesis and drug resistance and detect corresponding phenotypic alterations in these traits. Together, this tool will facilitate a broad range of applications for the study of C. albicans genetic overexpression.